Exergaming in patients with a left ventricular assist device: a feasibility study

被引:0
|
作者
Hammer, Yoav [1 ,2 ]
Shaul, Aviv A. [1 ,2 ]
Ben-Avraham, Binyamin [1 ,2 ]
Ben Zadok, Osnat Itzhaki [1 ,2 ]
Barac, Yaron D. [2 ,3 ]
Rubchevsky, Victor [2 ,3 ]
Yaari, Vicky [1 ,2 ]
Gutrov, Ema [1 ,2 ]
Stromberg, Anna [4 ,5 ]
Klompstra, Leonie [4 ]
Jaarsma, Tiny [4 ]
Ben-Gal, Tuvia [1 ,2 ]
机构
[1] Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Rabin Med Ctr, Dept Cardiothorac Surg, Petah Tiqwa, Israel
[4] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden
[5] Linkoping Univ, Dept Cardiol, Linkoping, Sweden
来源
ESC HEART FAILURE | 2023年 / 10卷 / 01期
基金
瑞典研究理事会;
关键词
Exergames; Left ventricular assist device; Heart failure; Exercise; Six-minute walk test; SOCIETY;
D O I
10.1002/ehf2.14203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Exercise games (exergames) have been recently proposed as a mode of facilitating physical activity in patients with chronic diseases. Although patients supported with left ventricular assist devices (LVADs) benefit from physical activity, specific LVAD-related issues hinder their ability to exercise properly. The objective of this study was to assess the feasibility and safety of exergaming in LVAD-supported patients. Methods and results Eleven LVAD-supported patients were enrolled in a 4 week exergaming programme using Nintendo Wii console with five sport games. Patients were instructed to play for 30 min a day, 5 days a week. Data on exercise capacity and exergaming were collected by using the 6 min walk test (6MWT) and a daily self-report diary, respectively. Feasibility of using the console and its safety was assessed by a semi-structured patient interview. Quality of life was assessed by the Minnesota Living with Heart failure Questionnaire (MLHFQ) and the Cantril's Ladder of Life. Safety was assessed by patient's report in interview and diary. The study group consisted of 10 male patients and 1 female patient, mean age of 67 +/- 7 years, of whom 10 were supported with the HeartMate 3 LVAD for a median of 10 (interquartile range 3, 21) months. Baseline exercise capacity assessed by the 6MWT ranged from 240 to 570 m (mean 448 +/- 112). After 4 weeks of exergaming, 6MWT distance increased from a mean of 448 +/- 112 (evaluated in six patients) to 472 +/- 113 m (P = 0.023). Patients' Cantril's Ladder of Life score improved numerically from an average of 6.13 to 7.67, as did their MLHFQ score from 45.9 +/- 27 to 38.7 +/- 18, with higher and lower scores, respectively, reflecting higher quality of life. No specific LVAD-related safety issues regarding exergaming were reported. Conclusions Exergaming was found to be a safe and feasible mode for encouraging physical activity in LVAD-supported patients and carries a potential for improving exercise capacity and quality of life in these patients. Larger scale studies are warranted to further investigate the effect of exergaming in this patient population.
引用
收藏
页码:738 / 741
页数:4
相关论文
共 50 条
  • [41] Left ventricular assist device - an update
    Florian, A.
    Machler, H.
    Renz, D.
    Zimpfer, D.
    JOURNAL FUR KARDIOLOGIE, 2022, 29 (9-10): : 258 - 262
  • [42] Left ventricular assist device for everybody?
    Loardi, Claudia Maria
    Zanobini, Marco
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 57 (04) : 810 - 810
  • [43] Biologisation of the Left Ventricular Assist Device
    Guentner, H.
    Katsirntaki, K.
    Pflaum, M.
    Haverich, A.
    Wiegmann, B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S300 - S300
  • [44] Endocarditis in left ventricular assist device
    Thyagarajan, Braghadheeswar
    Kumar, Monisha Priyadarshini
    Sikachi, Rutuja R.
    Agrawal, Abhinav
    INTRACTABLE & RARE DISEASES RESEARCH, 2016, 5 (03) : 177 - 184
  • [45] Nontuberculous mycobacterial infections in left ventricular assist device patients
    Radcliffe, Christopher
    Doilicho, Natnael
    Grant, Matthew
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (05) : 1138 - 1141
  • [46] Left ventricular assist device implantation in patients with a history of malignancy
    Hong, Yeahwa
    Seese, Laura
    Hickey, Gavin
    Chen, Shangzhen
    Mathier, Michael A.
    Kilic, Arman
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (09) : 2224 - 2231
  • [47] Anticoagulation Monitoring in Left Ventricular Assist Device (LVAD) Patients
    Sieg, A.
    Gass, J.
    Weeks, P.
    Brown, A.
    Rajapreyar, I.
    Gregoric, I.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S420 - S420
  • [48] INTERPRETATION OF TELEMETRY AMONG PATIENTS WITH A LEFT VENTRICULAR ASSIST DEVICE
    Dzikowicz, Dillon J.
    Suba, Sukardi
    Al-Zaiti, Salah S.
    Carey, Mary G.
    AMERICAN JOURNAL OF CRITICAL CARE, 2022, 31 (04) : 343 - 344
  • [49] Chronic outpatient management of patients with a left ventricular assist device
    Smith, Elisa M.
    Franzwa, Jennifer
    JOURNAL OF THORACIC DISEASE, 2015, 7 (12) : 2112 - 2124
  • [50] Left Ventricular Assist Device Therapy in "Cold and Dry" Patients
    Balgobind, Amrita
    Varrias, Dimitrios
    Patel, Snehal R.
    Safiriyu, Israel
    Spanos, Michail
    Villela, Miguel Alvarez
    CIRCULATION, 2023, 148